Clinical utility of 12‐lead electrocardiogram in evaluating heart disease in patients with muscular dystrophy: Assessment of left ventricular hypertrophy, conduction disease, and cardiomyopathy

Abstract Introduction Heart disease remains a leading cause of mortality in patients with muscular dystrophy (MD), and cardiac assessment by standard imaging modalities is challenging due to the prominence of physical limitations. Methods In this prospective cohort study of 169 MD patients and 34 ne...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anish Nikhanj, Haran Yogasundaram, Shane Kimber, Zaeem A. Siddiqi, Gavin Y. Oudit
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/7dfd824018f44e0d826d47bf169a7f4e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7dfd824018f44e0d826d47bf169a7f4e
record_format dspace
spelling oai:doaj.org-article:7dfd824018f44e0d826d47bf169a7f4e2021-11-12T11:40:14ZClinical utility of 12‐lead electrocardiogram in evaluating heart disease in patients with muscular dystrophy: Assessment of left ventricular hypertrophy, conduction disease, and cardiomyopathy1542-474X1082-720X10.1111/anec.12876https://doaj.org/article/7dfd824018f44e0d826d47bf169a7f4e2021-11-01T00:00:00Zhttps://doi.org/10.1111/anec.12876https://doaj.org/toc/1082-720Xhttps://doaj.org/toc/1542-474XAbstract Introduction Heart disease remains a leading cause of mortality in patients with muscular dystrophy (MD), and cardiac assessment by standard imaging modalities is challenging due to the prominence of physical limitations. Methods In this prospective cohort study of 169 MD patients and 34 negative control patients, we demonstrate the clinical utility of a 12‐lead electrocardiogram (ECG) as an effective modality for the assessment of cardiac status in patients with MD. We assessed the utility of conventional criteria for electrocardiogram‐indicated left ventricular hypertrophy (ECG‐LVH) as well as ECG morphologies. Results Cornell voltage, Cornell voltage‐duration, Sokolow–Lyon voltage, and Romhilt‐Estes point score criteria demonstrated low sensitivity and minimal positive predictive value for ECG‐LVH when compared with cardiac imaging. Patients with LBBB had a high probability of a cardiomyopathy (relative risk [RR], 2.75; 95% confidence interval [CI], 2.14–3.53; p < .001), and patients with QRS fragmentation (fQRS) had a high probability of a cardiomyopathy (RR, 1.76; 95% CI, 1.20–2.59; p = .004), requiring cardiac medication and device intervention. We found that an R/S ratio >1 in V1 and V2 is highly specific (specificity, 0.89; negative predictive value [NPV], 0.89 and specificity, 0.82; NPV, 0.89, respectively) for patients with dystrophinopathies compared with other types of MD. Conclusion The identification of LBBB and fQRS was linked to cardiomyopathy in patients with MD, while ECG‐LVH was of limited utility. Importantly, these findings can be applied to effectively screen a broad cohort of MD patients for structural heart disease and prompt further evaluation and therapeutic intervention.Anish NikhanjHaran YogasundaramShane KimberZaeem A. SiddiqiGavin Y. OuditWileyarticleelectrocardiogramleft bundle branch blockleft ventricular hypertrophymuscular dystrophyQRS fragmentationDiseases of the circulatory (Cardiovascular) systemRC666-701ENAnnals of Noninvasive Electrocardiology, Vol 26, Iss 6, Pp n/a-n/a (2021)
institution DOAJ
collection DOAJ
language EN
topic electrocardiogram
left bundle branch block
left ventricular hypertrophy
muscular dystrophy
QRS fragmentation
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle electrocardiogram
left bundle branch block
left ventricular hypertrophy
muscular dystrophy
QRS fragmentation
Diseases of the circulatory (Cardiovascular) system
RC666-701
Anish Nikhanj
Haran Yogasundaram
Shane Kimber
Zaeem A. Siddiqi
Gavin Y. Oudit
Clinical utility of 12‐lead electrocardiogram in evaluating heart disease in patients with muscular dystrophy: Assessment of left ventricular hypertrophy, conduction disease, and cardiomyopathy
description Abstract Introduction Heart disease remains a leading cause of mortality in patients with muscular dystrophy (MD), and cardiac assessment by standard imaging modalities is challenging due to the prominence of physical limitations. Methods In this prospective cohort study of 169 MD patients and 34 negative control patients, we demonstrate the clinical utility of a 12‐lead electrocardiogram (ECG) as an effective modality for the assessment of cardiac status in patients with MD. We assessed the utility of conventional criteria for electrocardiogram‐indicated left ventricular hypertrophy (ECG‐LVH) as well as ECG morphologies. Results Cornell voltage, Cornell voltage‐duration, Sokolow–Lyon voltage, and Romhilt‐Estes point score criteria demonstrated low sensitivity and minimal positive predictive value for ECG‐LVH when compared with cardiac imaging. Patients with LBBB had a high probability of a cardiomyopathy (relative risk [RR], 2.75; 95% confidence interval [CI], 2.14–3.53; p < .001), and patients with QRS fragmentation (fQRS) had a high probability of a cardiomyopathy (RR, 1.76; 95% CI, 1.20–2.59; p = .004), requiring cardiac medication and device intervention. We found that an R/S ratio >1 in V1 and V2 is highly specific (specificity, 0.89; negative predictive value [NPV], 0.89 and specificity, 0.82; NPV, 0.89, respectively) for patients with dystrophinopathies compared with other types of MD. Conclusion The identification of LBBB and fQRS was linked to cardiomyopathy in patients with MD, while ECG‐LVH was of limited utility. Importantly, these findings can be applied to effectively screen a broad cohort of MD patients for structural heart disease and prompt further evaluation and therapeutic intervention.
format article
author Anish Nikhanj
Haran Yogasundaram
Shane Kimber
Zaeem A. Siddiqi
Gavin Y. Oudit
author_facet Anish Nikhanj
Haran Yogasundaram
Shane Kimber
Zaeem A. Siddiqi
Gavin Y. Oudit
author_sort Anish Nikhanj
title Clinical utility of 12‐lead electrocardiogram in evaluating heart disease in patients with muscular dystrophy: Assessment of left ventricular hypertrophy, conduction disease, and cardiomyopathy
title_short Clinical utility of 12‐lead electrocardiogram in evaluating heart disease in patients with muscular dystrophy: Assessment of left ventricular hypertrophy, conduction disease, and cardiomyopathy
title_full Clinical utility of 12‐lead electrocardiogram in evaluating heart disease in patients with muscular dystrophy: Assessment of left ventricular hypertrophy, conduction disease, and cardiomyopathy
title_fullStr Clinical utility of 12‐lead electrocardiogram in evaluating heart disease in patients with muscular dystrophy: Assessment of left ventricular hypertrophy, conduction disease, and cardiomyopathy
title_full_unstemmed Clinical utility of 12‐lead electrocardiogram in evaluating heart disease in patients with muscular dystrophy: Assessment of left ventricular hypertrophy, conduction disease, and cardiomyopathy
title_sort clinical utility of 12‐lead electrocardiogram in evaluating heart disease in patients with muscular dystrophy: assessment of left ventricular hypertrophy, conduction disease, and cardiomyopathy
publisher Wiley
publishDate 2021
url https://doaj.org/article/7dfd824018f44e0d826d47bf169a7f4e
work_keys_str_mv AT anishnikhanj clinicalutilityof12leadelectrocardiograminevaluatingheartdiseaseinpatientswithmusculardystrophyassessmentofleftventricularhypertrophyconductiondiseaseandcardiomyopathy
AT haranyogasundaram clinicalutilityof12leadelectrocardiograminevaluatingheartdiseaseinpatientswithmusculardystrophyassessmentofleftventricularhypertrophyconductiondiseaseandcardiomyopathy
AT shanekimber clinicalutilityof12leadelectrocardiograminevaluatingheartdiseaseinpatientswithmusculardystrophyassessmentofleftventricularhypertrophyconductiondiseaseandcardiomyopathy
AT zaeemasiddiqi clinicalutilityof12leadelectrocardiograminevaluatingheartdiseaseinpatientswithmusculardystrophyassessmentofleftventricularhypertrophyconductiondiseaseandcardiomyopathy
AT gavinyoudit clinicalutilityof12leadelectrocardiograminevaluatingheartdiseaseinpatientswithmusculardystrophyassessmentofleftventricularhypertrophyconductiondiseaseandcardiomyopathy
_version_ 1718430628460888064